Company Financials

Pacira BioSciences, Inc. Financials

United States dollar

business Pacira BioSciences, Inc. Company Profile

Main Stock Listing

NASDAQ: PCRX

Market Capitalization $1.10 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 52.04
Forward PE 7.18
Price to Sales TTM $1.53
Price to Book MRQ $1.45
Enterprise to Revenue 1.72
Enterprise to EBITDA 8.18

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 2.99%
Operating Margin 7.33%
Return on Assets TTM 2.89%
Return on Equity TTM 2.90%

Income Statement

Revenue TTM $716,790,976
Revenue per Share TTM $15.76
Quarterly Revenue Growth 6.50%
Gross Profit TTM $470,651,008
EBITDA $167,246,000
Net Income to Common TTM $21,438,000
Diluted EPS TTM $0.47
Quarterly Earnings Growth YoY 6.49%

Balance Sheet

Total Cash MRQ $246,334,000
Total Cash per Share MRQ $5.73
Total Debt MRQ $
Total Debt to Equity MRQ 58.49
Current Ratio MRQ 5.26
Book Value per Share MRQ $16.93

Cash Flow

Operating Cash Flow TTM $141,436,992
Levered Free Cash Flow TTM $78,397,000

PCRX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 42,965,902
Float Shares 42,508,892
Avg 10 Volume 786,750
Avg 30 Volume None
Shares Short 7,343,873
Short Ratio 9.53
Short % of Shares 24.97%
% Held by Insiders 1.88%
% Held by Institutions 113.95%

Stock Price Summary

Beta 0.24
Fifty Two Week Low $18.17
Fifty Two Week High $27.64
Fifty Two Week Change 23.84%
Day 50 MA $23.88
Day 200 MA $24.51

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date